Kanis JA - Search Results

1

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.

Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE. Purohit OP, et al. Among authors: kanis ja. Br J Cancer. 1995 Nov;72(5):1289-93. doi: 10.1038/bjc.1995.502. Br J Cancer. 1995. PMID: 7577484 Free PMC article. Clinical Trial.

2

Comparative effects of intravenous diphosphonates on calcium and skeletal metabolism in man.

McCloskey EV, Yates AJ, Beneton MN, Galloway J, Harris S, Kanis JA. McCloskey EV, et al. Among authors: kanis ja. Bone. 1987;8 Suppl 1:S35-41. Bone. 1987. PMID: 2825741

3

Treatment of the hypercalcaemia of malignancy with intravenous clodronate.

Urwin GH, Yates AJ, Gray RE, Hamdy NA, McCloskey EV, Preston FE, Greaves M, Neil FE, Kanis JA. Urwin GH, et al. Among authors: kanis ja. Bone. 1987;8 Suppl 1:S43-51. Bone. 1987. PMID: 2961354

4

Clodronate in the medical management of hyperparathyroidism.

Hamdy NA, Gray RE, McCloskey E, Galloway J, Rattenbury JM, Brown CB, Kanis JA. Hamdy NA, et al. Among authors: kanis ja. Bone. 1987;8 Suppl 1:S69-77. Bone. 1987. PMID: 2961358

5

Treatment of malignant hypercalcaemia with clodronate.

Percival RC, Paterson AD, Yates AJ, Beard DJ, Douglas DL, Neal FE, Russell RG, Kanis JA. Percival RC, et al. Among authors: kanis ja. Br J Cancer. 1985 May;51(5):665-9. doi: 10.1038/bjc.1985.100. Br J Cancer. 1985. PMID: 3158326 Free PMC article.

6

Double-blind, placebo-controlled, dose-response trial of oral clodronate in patients with bone metastases.

O'Rourke N, McCloskey E, Houghton F, Huss H, Kanis JA. O'Rourke N, et al. Among authors: kanis ja. J Clin Oncol. 1995 Apr;13(4):929-34. doi: 10.1200/JCO.1995.13.4.929. J Clin Oncol. 1995. PMID: 7707121 Clinical Trial.

7

Tumour induced hypercalcaemia: a case for active treatment.

O'Rourke NP, McCloskey EV, Kanis JA. O'Rourke NP, et al. Among authors: kanis ja. Clin Oncol (R Coll Radiol). 1994;6(3):172-6. doi: 10.1016/s0936-6555(94)80057-x. Clin Oncol (R Coll Radiol). 1994. PMID: 8086352

8

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).

O'Rourke NP, McCloskey EV, Rosini S, Coleman RE, Kanis JA. O'Rourke NP, et al. Among authors: kanis ja. Br J Cancer. 1994 May;69(5):914-7. doi: 10.1038/bjc.1994.176. Br J Cancer. 1994. PMID: 8180023 Free PMC article.

9

Comparative effects of clodronate and calcitonin on bone in metastatic breast cancer: a histomorphometric study.

Taube T, Elomaa I, Blomqvist C, Beneton MN, Kanis JA. Taube T, et al. Among authors: kanis ja. Eur J Cancer. 1993;29A(12):1677-81. doi: 10.1016/0959-8049(93)90103-m. Eur J Cancer. 1993. PMID: 8398293 Clinical Trial.

10

Effective treatment of malignant hypercalcaemia with a single intravenous infusion of clodronate.

O'Rourke NP, McCloskey EV, Vasikaran S, Eyres K, Fern D, Kanis JA. O'Rourke NP, et al. Among authors: kanis ja. Br J Cancer. 1993 Mar;67(3):560-3. doi: 10.1038/bjc.1993.102. Br J Cancer. 1993. PMID: 8439504 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

876 results

Search Page

Filters